|
|
||||||||
Papers In Press, published online ahead of print September 16, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Biochemistry and Molecular Biology, Dalhousie University, Halifax, Nova Scotia B3H 4H7
Corresponding Author: nridgway{at}dal.ca
The cytotoxic effects of several chemotherapeutic drugs have been linked to elevated de novo ceramide biosynthesis. However, the relationship between the intracellular site(s) of ceramide accumulation and cytotoxicity is poorly understood. Here we examined the relationship between the site of ceramide deposition and inhibition of protein translation and induction of apoptosis by the antitumor/antiviral xanthate, D609. In CHO-K1, HEK-293 and NIH-3T3 cells, D609 caused rapid (1-5 min) and sustained eIF2
Revised on September 2, 2003
Accepted on September 8, 2003
The role of de novo ceramide synthesis in the mechanism of action of the tricyclic xanthate D609
phosphorylation followed by apoptosis after 24 h. Concurrently, D609 stimulated de novo ceramide synthesis and increased ceramide mass 2-fold by 2h in CHO-K1 cells. In D609-treated CHO-K1 cells, sphingomyelin synthesis was stimulated by brefeldin A and C5-DMB-ceramide transport to the Golgi apparatus was blocked, indicating ceramide accumulation in the endoplasmic reticulum. However, D609-mediated eIF2
phosphorylation, inhibition of protein synthesis and apoptosis in CHO-K1 cells was not attenuated by fumonisin B1 or L-cycloserine. Interestingly, short-chain ceramide promoted eIF2
phosphorylation and inhibited protein synthesis in CHO-K1 cells, indicating that the effectiveness of endogenous ceramide could be limited by access to signaling pathways. Thus expansion of the ER ceramide pool by D609 was not implicated in early (eIF2
phosphorylation) or late (apoptotic) cytotoxic events.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. Giussani, M. Maceyka, H. Le Stunff, A. Mikami, S. Lepine, E. Wang, S. Kelly, A. H. Merrill Jr., S. Milstien, and S. Spiegel Sphingosine-1-Phosphate Phosphohydrolase Regulates Endoplasmic Reticulum-to-Golgi Trafficking of Ceramide. Mol. Cell. Biol., July 1, 2006; 26(13): 5055 - 5069. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Perry and N. D. Ridgway Oxysterol-binding Protein and Vesicle-associated Membrane Protein-associated Protein Are Required for Sterol-dependent Activation of the Ceramide Transport Protein Mol. Biol. Cell, June 1, 2006; 17(6): 2604 - 2616. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bai, G. P. Meier, Y. Wang, C. Luberto, Y. A. Hannun, and D. Zhou Prodrug Modification Increases Potassium Tricyclo[5.2.1.02,6]-decan-8-yl Dithiocarbonate (D609) Chemical Stability and Cytotoxicity against U937 Leukemia Cells J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1051 - 1059. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |